NATUREX increases its risk exposure and slightly lowers to Neutral
NATUREX (FR), a company active in the Food Products industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date September 4, 2018, the closing price was EUR 134.60 and its expected value was estimated at EUR 134.86.Naturex produces and sells specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetics industries. Co. covers all of the businesses that use plant extracts. The two primary uses therein include: food extracts (sold directly to the food processing and flavor industries) and nutraceutical extracts. Co.'s operations are organized around three strategic and complementary markets: Food & Beverage, for food processing industries and flavoring specialists worldwide; Nutrition & Health, for the nutraceutical and pharmaceutical markets; and Personal Care, for the cosmetics industry plus beauty and care brands.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.